Acuta Capital Partners’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-365,618
| Closed | -$13.5M | – | 44 |
|
|
2022
Q3 | $13.5M | Buy |
365,618
+13,118
| +4% | +$486K | 5.83% | 4 |
|
|
2022
Q2 | $6.69M | Buy |
352,500
+10,500
| +3% | +$199K | 3.73% | 9 |
|
|
2022
Q1 | $9.23M | Sell |
342,000
-62,000
| -15% | -$1.67M | 4.31% | 5 |
|
|
2021
Q4 | $9.1M | Buy |
+404,000
| New | +$9.1M | 3.83% | 6 |
|
|
2021
Q1 | – | Sell |
-120,000
| Closed | -$3.85M | – | 57 |
|
|
2020
Q4 | $3.85M | Sell |
120,000
-157,000
| -57% | -$5.03M | 1.05% | 33 |
|
|
2020
Q3 | $10.4M | Buy |
277,000
+42,500
| +18% | +$1.6M | 2.83% | 11 |
|
|
2020
Q2 | $10.5M | Buy |
234,500
+143,550
| +158% | +$6.42M | 3.03% | 10 |
|
|
2020
Q1 | $3.1M | Buy |
+90,950
| New | +$3.1M | 1.5% | 24 |
|